Outlook Therapeutics ( ($OTLK) ) has released its Q1 earnings. Here is a breakdown of the information Outlook Therapeutics presented to its ...

European equities traded in the US as American depositary receipts were trending modestly lower late Friday morning, down 0.23% to 1,399.64 on the S&P Europe Select ADR Index. Despite the decline, the ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Before taking its repurposed diabetes drug candidate into a phase 2 lupus trial, Conduit Pharmaceuticals is tapping Charles ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Financing led by Velan Capital with participation from new and existing healthcare-focused institutional investors and ...

Investment trusts have a number of tricks up their sleeves that mean they can boost their dividend payouts. This is what to ...

Eco-lovers in the UK can now be buried in the world's first 'living coffin' - which decomposes faster and is made out of mushrooms.

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

VINCI successfully places €400 million cash-settled synthetic convertible bonds ...